HomeCLBIO • STO
add
Corline Biomedical AB
Previous close
kr 16.30
Day range
kr 16.00 - kr 16.35
Year range
kr 7.90 - kr 27.20
Market cap
400.42M SEK
Avg Volume
25.01K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.60M | -41.55% |
Operating expense | 4.34M | -5.90% |
Net income | -3.36M | -12.12% |
Net profit margin | -209.41 | -91.80% |
Earnings per share | — | — |
EBITDA | -3.36M | -12.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.82M | -20.67% |
Total assets | 82.31M | -11.53% |
Total liabilities | 5.09M | -40.44% |
Total equity | 77.23M | — |
Shares outstanding | 21.49M | — |
Price to book | 4.54 | — |
Return on assets | -9.98% | — |
Return on capital | -10.67% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.36M | -12.12% |
Cash from operations | -2.20M | 50.49% |
Cash from investing | -300.00K | 69.20% |
Cash from financing | — | — |
Net change in cash | -2.50M | 53.85% |
Free cash flow | -1.25M | 70.97% |
About
Founded
1991
Website
Employees
13
